Valuation: Aptahem AB

Chart: Aptahem AB

09-25	Aptahem enters letter of intent for collaboration with professor	FW
09-18	Aptahem trades today on Spotlight excluding unit rights in rights issue	FW
09-14	Aptahem carries out a rights issue, raising SEK 15.6m	FW
08-31	Aptahem steps up partnering work around Apta-1	FW
08-27	Aptahem AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-27	Aptahem reports, as expected, unchanged results, CEO: working to move Apta-1 forward	FW
08-25	Aptahem, Jarlen Capital Sign Asset Outlicensing, Commercial Partnership Deal	MT
08-25	Aptahem signs partnership agreement with Jarlen Capital	FW
06-17	Aptahem Improves Quality And Manufacturing Efficiency In A New Apta-1 Test Batch	CI
06-17	Aptahem Reports Improved Production of Apta-1	FW
05-28	Aptahem AB Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-28	Aptahem reports narrowed operating loss	FW
05-11	Aptahem to focus on conditions mirroring sepsis pathology - newsletter	FW

19/09/25

08-25	Aptahem: Aptahem enters commercial partnership agreement with Jarlen Capital for outlicensing	PU
08-25	Aptahem enters commercial partnership agreement with Jarlen Capital for outlicensing	AQ
06-22	Aptahem: Newsletter June 2026	PU
06-22	Newsletter June 2026	AQ
06-17	Aptahem: Aptahem Improves Quality and Manufacturing Efficiency in a New Apta-1 Test Batch	PU

Manager	Title	Age	Since
Luiza Jedlina CTO	Chief Tech/Sci/R&D Officer	-	29/02/2016
Knut Mikael Ingolf Lindstam CEO	Chief Executive Officer	60	31/12/2013
Ola Skanung DFI	Director of Finance/CFO	62	-

Director	Title	Age	Since
Knut Mikael Ingolf Lindstam BRD	Director/Board Member	60	31/12/2013
Johan Lindh BRD	Director/Board Member	-	-
Ulla Cristina Glad BRD	Director/Board Member	74	31/05/2016

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
APTAHEM AB	+4.65%	-5.26%	-70.25%	-98.43%	941K
WUXI APPTEC CO., LTD.	-0.37%	+1.12%	+57.21%	+84.56%	72.26B
ARGENX SE	-0.07%	-2.70%	+38.19%	+86.90%	60.24B
WUXI BIOLOGICS (CAYMAN) INC.	+0.75%	+6.06%	+36.71%	+19.87%	27.73B
INSMED INCORPORATED	+0.26%	-2.22%	-16.48%	+359.28%	25.73B
BIONTECH SE	+1.32%	+1.97%	+1.87%	-2.06%	24.75B
GENMAB A/S	+1.10%	+1.86%	+25.66%	-7.59%	20.74B
PHARMAESSENTIA CORPORATION	-1.70%	-2.12%	+150.24%	+323.16%	15.06B
EXELIXIS, INC.	+0.83%	+2.40%	+44.43%	+161.70%	14.41B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-2.53%	-1.39%	-6.38%	+469.36%	14.23B
Average	+0.42%	+0.99%	+26.12%	+139.67%	27.52B
Weighted average by Cap.	+0.00%	-1.05%	+37.87%	+126.51%

Aptahem AB is a manufacturer of biological products. The company was founded in 2014 and is located in Malmo, Sweden.

Employees

Sector

Date	Price	Change	Volume
25/09/26	SEK 0.3600	+4.65%	205,741
24/09/26	SEK 0.3440	+9.21%	75,538
23/09/26	SEK 0.3150	+1.29%	230,657
22/09/26	SEK 0.3110	-4.01%	495,348
21/09/26	SEK 0.3240	-14.74%	344,308